Ist Central Asia Transplantation and Cellular Therapy Meeting
September 4-5, 2025
Program at a Glance
Download as file
09:00-09:30Grand opening. Welcome speechProf. Asilbek Khudayarov, Ministry of Health of the Republic of Uzbekistan
09:30-09:50State and Prospects for the Development of Hematology in UzbekistanDr. Miralisher Islamov (Uzbekistan)
10:00-10:20Skin lymphoma in UzbekistanProf. Akmal Sidikov (Uzbekistan)
10:20-10:40Primary Cutaneous T-cell Lymphomas: Russian ExperienceDr. Liliya Gorenkova (Russia)
10:40-11:00Experience and Outcomes of Autologous HSCT in Multiple Myeloma in KazakhstanDr. Azat Karabekov (Kazakhstan)
11:00-11:20Results of Autologous HSCT in Multiple Myeloma in UzbekistanDr. Gulchekhra Makhamadalieva (Uzbekistan)
11:20-11:40Outcomes of HSCT in Multiple Myeloma at the National Medical Research Center of HematologyDr. Maxim Solovev (Russia)
11:40-12:00Autologous HSCT for Lymphomas in TürkiyeProf. Sinan Demircioğlu (Türkiye)
12:00-12:20Transplantation and CAR‑T Therapy in Diffuse Large B‑Cell Lymphoma Prof. Duzgun Ozetli (Türkiye)
12:20-13:20Lunch
13:20-13:40Case report: cGVHD treatment in KazakhstanProf. Vadim Kemaykin (Kazakhstan)
13:40-14:00GVHD structure and treatment approaches in GeorgiaDr. Nino Sharashenidze (Georgia)
14:20-14:40GVHD Landscape in UzbekistanDr. Abdurakhmon Kayumov (Uzbekistan)
14:40-15:00Recommendations of Russian Society for Hematopoietic Stem Cell Transplantation, Gene and Cell therapy for diagnosis and treatment of graft-versus-host disease Prof. Ivan Moiseev (Russia)
15:00-15:20Mesenchymal Stromal Cells in GVHD Treatment: Experience of Republic of BelarusDr. Oksana Morozova (Republic of Belarus)
15:20-15:40Decidual stromal cell (DSCs): A novel and promising cell therapy product for SR-GVHD Dr. Abbas Haji Fatali (Iran)
15:40-16:00Use of G-CSF and aTPO in allo-HSCTDr. Mikhail Drokov (Russia)
19:00Gala Dinner at Sultan Said
